BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11228359)

  • 1. Capsid and RNA stabilisation of the oral polio vaccine.
    Verheyden B; Andries K; Rombaut B
    Vaccine; 2001 Feb; 19(15-16):1899-905. PubMed ID: 11228359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilisation of poliovirus with pirodavir.
    Rombaut B; Andries K; Boeyé A
    Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine.
    Crainic R; Wu R; Otelea D; Georgescu MM; Delpeyroux F; Guillot S; Balanant J; Tardy-Panit M
    Dev Biol Stand; 1996; 87():161-6. PubMed ID: 8854013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermostability of vaccines. Technologies for improving the thermostability of the oral poliovirus vaccine.
    Lemon SM; Milstien JB
    Int J Technol Assess Health Care; 1994; 10(1):177-84. PubMed ID: 8157450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.
    Rombaut B; Verheyden B; Andries K; Boeyé A
    J Virol; 1994 Oct; 68(10):6454-7. PubMed ID: 8083982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water isotope effect on the thermostability of a polio viral RNA hairpin: A metadynamics study.
    Pathak AK; Bandyopadhyay T
    J Chem Phys; 2017 Apr; 146(16):165104. PubMed ID: 28456205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory considerations for new stabilised poliovaccines.
    Milstien JB; Lemon S
    Dev Biol Stand; 1996; 87():181-9. PubMed ID: 8854016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the loss of infectivity of live type 3 poliovaccine on storage.
    Pipkin PA; Minor PD
    Biologicals; 1998 Mar; 26(1):17-23. PubMed ID: 9637745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermostability of poliovirus and measles vaccines.
    Melnick JL
    Dev Biol Stand; 1996; 87():155-60. PubMed ID: 8854012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound.
    Andries K; Rombaut B; Dewindt B; Boeyé A
    J Virol; 1994 May; 68(5):3397-400. PubMed ID: 8151800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilising oral poliovaccine at high ambient temperatures.
    Newman JF; Tirrell S; Ullman C; Piatti PG; Brown F
    Dev Biol Stand; 1996; 87():103-11. PubMed ID: 8854007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae.
    Rombaut B; Jore JP
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1829-32. PubMed ID: 9266976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2.
    Chen CH; Wu R; Roth LG; Guillot S; Crainic R
    Arch Biochem Biophys; 1997 Jun; 342(1):108-16. PubMed ID: 9185619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
    Barnard DL; Hubbard VD; Smee DF; Sidwell RW; Watson KG; Tucker SP; Reece PA
    Antimicrob Agents Chemother; 2004 May; 48(5):1766-72. PubMed ID: 15105133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a more thermostable poliovirus vaccine.
    Milstien JB; Lemon SM; Wright PF
    J Infect Dis; 1997 Feb; 175 Suppl 1():S247-53. PubMed ID: 9203724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model describing the thermal virus inactivation.
    Noël C; Charles S; Françon A; Flandrois JP
    Vaccine; 2001 May; 19(25-26):3575-82. PubMed ID: 11348725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
    Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
    Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    J Virol; 1993 Apr; 67(4):2367-9. PubMed ID: 8383247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical studies of viral capsid proteins.
    Phelps DK; Speelman B; Post CB
    Curr Opin Struct Biol; 2000 Apr; 10(2):170-3. PubMed ID: 10753813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.